You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
| Title |
Dutasteride plus Tamsulosin fixed-dose combination first-line therapy versus Tamsulosin Monotherapy in the treatment of benign prostatic hyperplasia: a budget impact analysis in the Greek healthcare setting
|
|---|---|
| Published in |
BMC Urology, September 2014
|
| DOI | 10.1186/1471-2490-14-78 |
| Pubmed ID | |
| Authors |
Maria Geitona, Pinelopi Karabela, Ioannis A Katsoulis, Hara Kousoulakou, Eleni Lyberopoulou, Eleftherios Bitros, Loukas Xaplanteris, Sotiria Papanicolaou |
| Abstract |
The purpose of this study was to explore the budget impact of dutasteride plus tamsulosin fixed-dose combination (DUT + TAM FDC) versus tamsulosin monotherapy, in the treatment of patients with benign prostatic hyperplasia (BPH) from the perspective of the Greek healthcare insurance system. |
Mendeley readers
The data shown below were compiled from readership statistics for 41 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Mexico | 1 | 2% |
| Unknown | 40 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 14 | 34% |
| Other | 8 | 20% |
| Researcher | 7 | 17% |
| Student > Doctoral Student | 3 | 7% |
| Student > Ph. D. Student | 2 | 5% |
| Other | 2 | 5% |
| Unknown | 5 | 12% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 8 | 20% |
| Pharmacology, Toxicology and Pharmaceutical Science | 6 | 15% |
| Economics, Econometrics and Finance | 5 | 12% |
| Business, Management and Accounting | 4 | 10% |
| Engineering | 3 | 7% |
| Other | 8 | 20% |
| Unknown | 7 | 17% |